Literature DB >> 16889602

Acute oxalate nephropathy: A new etiology for acute renal failure following nonrenal solid organ transplantation.

C Lefaucheur1, G S Hill, C Amrein, J-P Haymann, C Jacquot, D Glotz, D Nochy.   

Abstract

Acute renal insufficiency (ARI) is a frequent complication of nonrenal solid organ transplantation and may be responsible for an unfavorable outcome, particularly if dialysis is required. The etiology of post-transplantation ARI is poorly understood, with only isolated clinical cases being reported, most imputed to drug toxicity. We report here, the first three observations of irreversible ARI associated with acute oxalate nephropathy (AON) in the course of nonrenal organ transplants: a lung transplant and a lung-liver transplant in two patients with mucoviscidosis, and a cardiac transplant. The diagnosis of AON was made histologically. In all three cases, the ARI supervened after prolonged consumption of antibiotics capable of interfering with the colonic flora, and leading to enteric hyperoxaluria. The recognition of AON as a cause of post-transplantation, ARI underlines hyperoxaluria and digestive hyperabsorption of oxalate as specific risk factors for AON and should permit better posttransplant care of these patients.

Entities:  

Mesh:

Year:  2006        PMID: 16889602     DOI: 10.1111/j.1600-6143.2006.01485.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  11 in total

1.  Oxalate nephropathy associated with chronic pancreatitis.

Authors:  Claire Cartery; Stanislas Faguer; Alexandre Karras; Olivier Cointault; Louis Buscail; Anne Modesto; David Ribes; Lionel Rostaing; Dominique Chauveau; Patrick Giraud
Journal:  Clin J Am Soc Nephrol       Date:  2011-07-07       Impact factor: 8.237

Review 2.  An unexpected cause of progressive renal failure in a 66-year-old male after liver transplantation: secondary hyperoxaluria.

Authors:  François Beloncle; Johnny Sayegh; Agnès Duveau; Virginie Besson; Anne Croue; Jean-François Subra; Jean-François Augusto
Journal:  Int Urol Nephrol       Date:  2012-03-01       Impact factor: 2.370

Review 3.  Nephropathy in dietary hyperoxaluria: A potentially preventable acute or chronic kidney disease.

Authors:  Robert H Glew; Yijuan Sun; Bruce L Horowitz; Konstantin N Konstantinov; Marc Barry; Joanna R Fair; Larry Massie; Antonios H Tzamaloukas
Journal:  World J Nephrol       Date:  2014-11-06

Review 4.  Oxalate, inflammasome, and progression of kidney disease.

Authors:  Theresa Ermer; Kai-Uwe Eckardt; Peter S Aronson; Felix Knauf
Journal:  Curr Opin Nephrol Hypertens       Date:  2016-07       Impact factor: 2.894

5.  Acute oxalate nephropathy following kidney transplantation: Report of three cases.

Authors:  Diana Taheri; Alaleh Gheissari; Pooria Shaabani; Seyed Reza Tabibian; Mojgan Mortazavi; Shiva Seirafian; Alireza Merrikhi; Mehdi Fesharakizadeh; Shahaboddin Dolatkhah
Journal:  J Res Med Sci       Date:  2015-08       Impact factor: 1.852

6.  Oxalate nephropathy induced by octreotide treatment for acromegaly: a case report.

Authors:  Karim Gariani; Sophie de Seigneux; Marie Courbebaisse; Marc Lévy; Solange Moll; Pierre-Yves Martin
Journal:  J Med Case Rep       Date:  2012-07-23

7.  Acute renal failure, microangiopathic haemolytic anemia, and secondary oxalosis in a young female patient.

Authors:  Karolina M Stepien; Peter Prinsloo; Tony Hitch; Thomas A McCulloch; Rebecca Sims
Journal:  Int J Nephrol       Date:  2011-07-19

8.  Transplantation for renal failure secondary to enteric hyperoxaluria: a case report.

Authors:  Stephen I Rifkin
Journal:  J Med Case Rep       Date:  2007-06-25

9.  Secondary oxalosis induced acute kidney injury in allograft kidneys.

Authors:  Manish Suneja; Avinash B Kumar
Journal:  Clin Kidney J       Date:  2013-01-04

10.  Acute kidney injury after ingestion of rhubarb: secondary oxalate nephropathy in a patient with type 1 diabetes.

Authors:  Marc Albersmeyer; Robert Hilge; Angelika Schröttle; Max Weiss; Thomas Sitter; Volker Vielhauer
Journal:  BMC Nephrol       Date:  2012-10-30       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.